Approval – Page 109 – pharmaceutical daily

January 26, 2017 Off

UPDATE: Johnson & Johnson buys Actelion for $30 billion

Johnson & Johnson said on Wednesday it will buy a Switzerland-based pharmaceutical company Actelion for $30 billion.

January 26, 2017 Off

Ablynx, Merck KGaA report encouraging results from psoriasis treatment study

By Dino Mustafić

Ablynx and Merck KGaA (Germany) have reported encouraging results from a study in psoriasis patients with the bi-specific Nanobody anti-IL-17A/F (M1095), via a clinical trials website (https://clinicaltrials.gov/NCT02156466).

January 25, 2017 Off

ImmuPharma recruits patients for Lupus drug testing

By Dino Mustafić

ImmuPharma has provided details of patient recruitment into its pivotal 52-week Phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough compound for Lupus.

January 25, 2017 Off

Beximco Pharma in JV with Malaysia-based BioCare Manufacturing

By Dino Mustafić

Beximco Pharmaceuticals has went overseas to form a joint venture (JV) with a Malaysia-based BioCare Manufacturing. This is the Bangladesh’s company’s first such JV.

January 25, 2017 Off

Neovacs tests its Lupus drug for Type 1 Diabetes treatment

By Dino Mustafić

Neovacs’s Scientific Advisory Board has recommended extension of the development of IFN Kinoid to a new indication, Type 1 Diabetes, with the objectives of obtaining preclinical proof of concept in 2017 and initiating clinical development for this program in the first half of 2018.

January 25, 2017 Off

Novartis 2016 full year net income down 6%

By Dino Mustafić

Novartis delivered a solid performance in 2016, absorbing Gleevec US loss of exclusivity while investing in key launches and the Alcon Division turnaround

January 25, 2017 Off

InnovaDerma misses deal with Korean distributor, seeks new negotiating round

By Dino Mustafić

The deal InnovaDerma had with PROS International Company of Korea to sell InnovaDerma products in a terrotiroy of S Korea, Japan, China and Russia has breaken apart, the UK based maker of hair and skin care products said on Wednesday.